Literature DB >> 17536690

Inhibitory activity of colicin E1 against Listeria monocytogenes.

Brenda S Patton1, James S Dickson, Steven M Lonergan, Sara A Cutler, Chad H Stahl.   

Abstract

Colicins are gram-negative bacteriocins produced by and effective against Escherichia coli and related species. Colicin E1 (ColE1) is composed of three functional domains, which collectively have a pore-forming effect on targeted bacteria. ColE1 binding and translocation domains are highly specific in contrast to the pore-forming domain, implying that ColE1 could be broadly effective. In this study, the activity of ColE1 against Listeria monocytogenes was evaluated in broth and on surfaces of ready-to-eat products. Individual strains of L. monocytogenes were examined in broth containing ColE1 at 0, 0.1, 1, or 10 microg/ml. Although strain differences in sensitivity to ColE1 existed, growth was significantly reduced in all strains at doses as low as 0.1 microg/ml. Sterilized ham slices were submerged in a five-strain L. monocytogenes cocktail (either 7 or 4 log CFU/ ml) and placed in vacuum packages containing 0, 1, 5, 10, 25, or 50 microg of ColE1. Ham slices were then stored at 4 or 10 degrees C, and samples were removed and examined for L. monocytogenes after 1, 3, 7, and 14 days. Reduction of L. monocytogenes by ColE1 was dependent on initial inoculum concentration and storage temperature. For slices stored at 4 degrees C, treatment with 25 microg reduced Listeria growth below detection limits for the slices inoculated with 4 log CFU/ml for the entire 14 days, whereas for the 7-log CFU/ml slices, growth was detected at 7 days postinoculation. For slices stored at 10 degrees C, 10 microg/ml ColE1 significantly inhibited growth of L. monocytogenes for up to 3 days for both inoculation groups. These data indicate that ColE1 is highly effective against Listeria.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17536690     DOI: 10.4315/0362-028x-70.5.1256

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  7 in total

1.  Smarter arrow now available in the food safety quiver.

Authors:  Todd R Callaway; Trisha G Sheridan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-23       Impact factor: 11.205

Review 2.  Structural and functional insights into colicin: a new paradigm in drug discovery.

Authors:  Ankita Pal; Papri Nath; Fatema Calcuttawala; Riya Kar; Debraj Hazra; Rajat Pal
Journal:  Arch Microbiol       Date:  2021-12-20       Impact factor: 2.552

3.  Dietary inclusion of colicin e1 is effective in preventing postweaning diarrhea caused by F18-positive Escherichia coli in pigs.

Authors:  S A Cutler; S M Lonergan; N Cornick; A K Johnson; C H Stahl
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

4.  Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia.

Authors:  Maruška Budič; Matija Rijavec; Ziva Petkovšek; Darja Zgur-Bertok
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

5.  Colicin FY inhibits pathogenic Yersinia enterocolitica in mice.

Authors:  Juraj Bosák; Lenka Micenková; Matěj Hrala; Katarína Pomorská; Michaela Kunova Bosakova; Pavel Krejci; Eduard Göpfert; Martin Faldyna; David Šmajs
Journal:  Sci Rep       Date:  2018-08-16       Impact factor: 4.379

6.  Colicin Z, a structurally and functionally novel colicin type that selectively kills enteroinvasive Escherichia coli and Shigella strains.

Authors:  Lenka Micenková; Juraj Bosák; Jiri Kucera; Matěj Hrala; Tereza Dolejšová; Ondrej Šedo; Dirk Linke; Radovan Fišer; David Šmajs
Journal:  Sci Rep       Date:  2019-07-31       Impact factor: 4.379

Review 7.  Colicins and Microcins Produced by Enterobacteriaceae: Characterization, Mode of Action, and Putative Applications.

Authors:  Katarina G Marković; Mirjana Ž Grujović; Maja G Koraćević; Danijela D Nikodijević; Milena G Milutinović; Teresa Semedo-Lemsaddek; Milan D Djilas
Journal:  Int J Environ Res Public Health       Date:  2022-09-19       Impact factor: 4.614

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.